Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06194448
Title To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations (NEOLA)
Acronym NEOLA
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Research Site La Jolla California 92093 United States Details
Research Site Los Angeles California 90095 United States Details
Research Site Palo Alto California 94304 United States Details
Research Site Brooklyn New York 11220 United States Details
Research Site Pittsburgh Pennsylvania 15232 United States Details
Research Site Beijing Shi 100021 China Details
Research Site Changsha 410013 China Details
Research Site Guangzhou 510060 China Details
Research Site Hangzhou 310022 China Details
Research Site Harbin 150081 China Details
Research Site Hefei 230001 China Details
Research Site Jinan 250117 China Details
Research Site Nanning 530021 China Details
Research Site Shanghai 200032 China Details
Research Site Shaoguan Shi 512025 China Details
Research Site Tianjin Shi 300060 China Details
Research Site Wuhan 430022 China Details
Research Site Wuhan 430071 China Details
Research Site Xi'an 710061 China Details
Research Site Zhengzhou 450052 China Details
Research Site Gurgaon 122001 India Details
Research Site Mohali 160055 India Details
Research Site Mumbai 400012 India Details
Research Site New Delhi 110085 India Details
Research Site Pune 411004 India Details
Research Site Haifa 31096 Israel Details
Research Site Jerusalem 91031 Israel Details
Research Site Petach-Tikva 4941492 Israel Details
Research Site Tel Aviv 62748 Israel Details
Research Site Cheongju-si 28644 Korea, Republic of Details
Research Site Seongnam-si 13620 Korea, Republic of Details
Research Site Seoul 03080 Korea, Republic of Details
Research Site Seoul 03722 Korea, Republic of Details
Research Site Seoul 06351 Korea, Republic of Details
Research Site Suwon 16247 Korea, Republic of Details
Research Site Badalona 08916 Spain Details
Research Site Barcelona 08003 Spain Details
Research Site Barcelona 08907 Spain Details
Research Site Donostia-San Sebastian 20014 Spain Details
Research Site Granada 18016 Spain Details
Research Site Madrid 28007 Spain Details
Research Site Madrid 28050 Spain Details
Research Site Valencia 46026 Spain Details
Research Site Hsinchu 300 Taiwan Details
Research Site Taichung 402 Taiwan Details
Research Site Tainan City 73657 Taiwan Details
Research Site Tainan 704 Taiwan Details
Research Site Taipei City 11217 Taiwan Details
Research Site Taipei 10002 Taiwan Details
Research Site Taipei 11259 Taiwan Details
Research Site Bangkok 10210 Thailand Details
Research Site Bangkok 10330 Thailand Details
Research Site Chiang Rai 57000 Thailand Details
Research Site Hat Yai 90110 Thailand Details
Research Site Khlong Toey 10110 Thailand Details
Research Site Khon Kaen 40002 Thailand Details
Research Site Lampang 52000 Thailand Details
Research Site Naimuang 30000 Thailand Details
Research Site Rachathewi 10400 Thailand Details
Research Site Ankara 06010 Turkey Details
Research Site Ankara 06830 Turkey Details
Research Site Edirne 22030 Turkey Details
Research Site Istanbul 34214 Turkey Details
Research Site Istanbul 34722 Turkey Details
Research Site Izmir 35575 Turkey Details
Research Site Yenimahalle 06170 Turkey Details
Research Site Yenimahalle 06560 Turkey Details
Research Site Hanoi 100000 Vietnam Details
Research Site Hanoi 123 Vietnam Details
Research Site Ho Chi Minh 700000 Vietnam Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field